UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 102

Sortiert nach

Safety and immunogenicity of one versus two doses of Takeda's tetravalent dengue vaccine in children in Asia and Latin America: interim results from a phase 2, randomised, placebo-controlled study

The Lancet infectious diseases, 2017-06, Vol.17 (6), p.615-625

2017

Volltextzugriff (PDF)

Safety of primary immunization with a DTwP-HBV/Hib vaccine in healthy infants: a prospective, open-label, interventional, phase IV clinical study

Expert review of vaccines, 2022-05, Vol.21 (5), p.685-692

2022

Volltextzugriff (PDF)

Shortening intradermal rabies post-exposure prophylaxis regimens to 1 week: Results from a phase III clinical trial in children, adolescents and adults

PLoS neglected tropical diseases, 2018-06, Vol.12 (6), p.e0006340-e0006340

2018

Volltextzugriff (PDF)

Safety and immunogenicity of 3 formulations of a Sabin inactivated poliovirus vaccine produced on the PER.C6® cell line: A phase 2, double-blind, randomized, controlled study in infants vaccinated at 6, 10 and 14 weeks of age

Human vaccines & immunotherapeutics, 2022-11, Vol.18 (5), p.2044255-2044255

2022

Volltextzugriff (PDF)

Efficacy of a Tetravalent Dengue Vaccine in Healthy Children and Adolescents

The New England journal of medicine, 2019-11, Vol.381 (21), p.2009-2019

2019

Volltextzugriff (PDF)

Efficacy of a tetravalent dengue vaccine in healthy children aged 4–16 years: a randomised, placebo-controlled, phase 3 trial

The Lancet (British edition), 2020-05, Vol.395 (10234), p.1423-1433

2020

Volltextzugriff (PDF)

Safety and immunogenicity of a tetravalent dengue vaccine in children aged 2–17 years: a randomised, placebo-controlled, phase 2 trial

The Lancet (British edition), 2020-05, Vol.395 (10234), p.1434-1443

2020

Volltextzugriff (PDF)

Immunogenicity and safety of one versus two doses of tetravalent dengue vaccine in healthy children aged 2–17 years in Asia and Latin America: 18-month interim data from a phase 2, randomised, placebo-controlled study

The Lancet infectious diseases, 2018-02, Vol.18 (2), p.162-170

2018

Volltextzugriff (PDF)

Immunogenicity, safety, and efficacy of a tetravalent dengue vaccine in children and adolescents: an analysis by age group

Clinical infectious diseases, 2024-07

2024

Volltextzugriff (PDF)

Safety of Adding Salmeterol to Fluticasone Propionate in Children with Asthma

The New England journal of medicine, 2016-09, Vol.375 (9), p.840-849

2016

Volltextzugriff (PDF)

Hepatic macrophages play critical roles in the establishment and growth of hydatid cysts in the liver during Echinococcus granulosus sensu stricto infection

PLoS neglected tropical diseases, 2023-11, Vol.17 (11), p.e0011746-e0011746

2023

Volltextzugriff (PDF)

Distinct effector memory CD4+ T cell signatures in latent Mycobacterium tuberculosis infection, BCG vaccination and clinically resolved tuberculosis

PloS one, 2012-04, Vol.7 (4), p.e36046-e36046

2012

Volltextzugriff (PDF)

Sustained treatment of retinal vascular diseases with self-aggregating sunitinib microparticles

Nature communications, 2020-02, Vol.11 (1), p.694-13, Article 694

2020

Volltextzugriff (PDF)

Bioresorbable silicon electronics for transient spatiotemporal mapping of electrical activity from the cerebral cortex

Nature materials, 2016-07, Vol.15 (7), p.782-791

2016

Volltextzugriff (PDF)

Adenomyosis incidence, prevalence and treatment: United States population-based study 2006–2015

American journal of obstetrics and gynecology, 2020-07, Vol.223 (1), p.94.e1-94.e10

2020

Volltextzugriff (PDF)

Derivation of sheep embryonic stem cells under optimized conditions

Reproduction (Cambridge, England), 2020-11, Vol.160 (5), p.761-772

2020

Volltextzugriff (PDF)

Health and climate change: policy responses to protect public health

The Lancet (British edition), 2015-11, Vol.386 (10006), p.1861-1914

2015

Volltextzugriff (PDF)

Predicting human olfactory perception from chemical features of odor molecules

Science (American Association for the Advancement of Science), 2017-02, Vol.355 (6327), p.820-826

2017

Volltextzugriff (PDF)

An innovative reuse of bottom ash from municipal solid waste incinerators as substrates of constructed wetlands

Chemosphere (Oxford), 2022-11, Vol.307, p.135896-135896, Article 135896

2022

Volltextzugriff (PDF)

Synthetic Control of Intrinsic Defect Formation in Metal Oxide Nanocrystals Using Dissociated Spectator Metal Salts

Journal of the American Chemical Society, 2022-12, Vol.144 (50), p.22941-22949

2022

Volltextzugriff (PDF)

78: A British Columbia Based Population Study on the Treatment and Long-Term Outcomes of Thymoma: A 25-Year Retrospective Review

Radiotherapy and oncology, 2022-09, Vol.174, p.S35

2022

Volltextzugriff (PDF)

1 – 25 von 102

Suche als RSS-Feed

Aktive Filter

PublikationsformBücher

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(93)
Mit Volltextzugriff
(95)

Publikationsform

Sprache

Englisch
(101)
Japanisch
(11)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Safety and immunogenicity of one versus two doses of Takeda's tetravalent dengue vaccine in children in Asia and Latin America: interim results from a phase 2, randomised, placebo-controlled study

Safety of primary immunization with a DTwP-HBV/Hib vaccine in healthy infants: a prospective, open-label, interventional, phase IV clinical study

Shortening intradermal rabies post-exposure prophylaxis regimens to 1 week: Results from a phase III clinical trial in children, adolescents and adults

Safety and immunogenicity of 3 formulations of a Sabin inactivated poliovirus vaccine produced on the PER.C6® cell line: A phase 2, double-blind, randomized, controlled study in infants vaccinated at 6, 10 and 14 weeks of age

Efficacy of a Tetravalent Dengue Vaccine in Healthy Children and Adolescents

Three-year Efficacy and Safety of Takeda’s Dengue Vaccine Candidate (TAK-003)

Efficacy of a tetravalent dengue vaccine in healthy children aged 4–16 years: a randomised, placebo-controlled, phase 3 trial

Safety and immunogenicity of a tetravalent dengue vaccine in children aged 2–17 years: a randomised, placebo-controlled, phase 2 trial

Immunogenicity and safety of one versus two doses of tetravalent dengue vaccine in healthy children aged 2–17 years in Asia and Latin America: 18-month interim data from a phase 2, randomised, placebo-controlled study

Immunogenicity, safety, and efficacy of a tetravalent dengue vaccine in children and adolescents: an analysis by age group

Efficacy of a Dengue Vaccine Candidate (TAK-003) in Healthy Children and Adolescents 2 Years after Vaccination

Safety of Adding Salmeterol to Fluticasone Propionate in Children with Asthma

Efficacy and Safety of a Tetravalent Dengue Vaccine (TAK-003) in Children With Prior Japanese Encephalitis or Yellow Fever Vaccination

Long-term efficacy and safety of a tetravalent dengue vaccine (TAK-003): 4·5-year results from a phase 3, randomised, double-blind, placebo-controlled trial

Hepatic macrophages play critical roles in the establishment and growth of hydatid cysts in the liver during Echinococcus granulosus sensu stricto infection

Distinct effector memory CD4+ T cell signatures in latent Mycobacterium tuberculosis infection, BCG vaccination and clinically resolved tuberculosis

Sustained treatment of retinal vascular diseases with self-aggregating sunitinib microparticles

Bioresorbable silicon electronics for transient spatiotemporal mapping of electrical activity from the cerebral cortex

Adenomyosis incidence, prevalence and treatment: United States population-based study 2006–2015

Derivation of sheep embryonic stem cells under optimized conditions

Health and climate change: policy responses to protect public health

Predicting human olfactory perception from chemical features of odor molecules

An innovative reuse of bottom ash from municipal solid waste incinerators as substrates of constructed wetlands

Synthetic Control of Intrinsic Defect Formation in Metal Oxide Nanocrystals Using Dissociated Spectator Metal Salts

78: A British Columbia Based Population Study on the Treatment and Long-Term Outcomes of Thymoma: A 25-Year Retrospective Review

Aktive Filter

Suchergebnisse filtern